Keverprazan
KY20240419-15
Approved small_molecule active
Quick answer
Keverprazan for H. Pylori Infection is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- H. Pylori Infection
- Phase
- Approved
- Modality
- small_molecule
- Status
- active